Treatment of Cryofibrinogenemia in Venous Thrombosis

Venous thrombotic events are a recognised complication in patients with cryofibrinogenemia. Their occurrence justifies a specific, sustained antithrombotic management approach.

Clinical scenario: Cryofibrinogenemia with venous thrombosis. The development of venous thrombotic events in this setting warrants targeted maintenance antithrombotic treatment.

Treatment Approach

Management in this scenario centres on an oral anticoagulation strategy — the complete regimen, agent selection, and clinical algorithm are detailed in the full protocol.

Full evidence-based regimen available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/rheumatology/kew379

The occurrence of arterial and venous thrombotic events in patients with CF justifies maintenance treatment with antithrombotic medications.

Patients with venous thrombosis apparently require administration of oral anticoagulants while patients with arterial thrombotic complications should probably be given low-dose aspirin alone or in combination with anticoagulants.

View source ↗